ClinicalTrials.Veeva

Menu

Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health (MilkCorona)

I

Institute of Agrochemistry and Food Technology, National Research Council

Status

Completed

Conditions

Covid19

Treatments

Other: maternal SARS-CoV-2 infection

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

prospective multicenter study The main aim is to study the impact of maternal COVID-19 on breast milk immune, microbiological, and metabolic profile and infant growth and development

Enrollment

100 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnant or nursing women with positive PCR for SARS-CoV-2 in nasopharynge and/or presence of SARS-CoV-2 antibodies in serum determined in hospitals

Exclusion criteria

  • aggravation of symptomatology requiring specific treatment and/or hospitalization

Trial design

100 participants in 1 patient group

COVID19
Description:
- Women with SARS-CoV-2 infections
Treatment:
Other: maternal SARS-CoV-2 infection

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems